[Federal Register Volume 67, Number 180 (Tuesday, September 17, 2002)]
[Notices]
[Page 58624]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-23556]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-6 p.m., October 16, 2002. 8 a.m.-2:45 
p.m., October 17, 2002.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: The agenda will include an update on 
the smallpox vaccination policy; supplemental recommendations for 
smallpox; 2003 recommended childhood immunization schedule and 
catch-up child immunization schedule; recommendations for storage of 
vaccines; 2003 influenza vaccine recommendations; update on 
influenza vaccine supply; update from the National Immunization 
Program; update from the Department of Defense; update from the Food 
and Drug Administration; update from the National Institutes of 
Health; update from the National Vaccine Program Office; update from 
Vaccine Injury Compensation Program; update from the National Center 
for Infectious Diseases; public participation in formulating vaccine 
policy; vaccinating cochlear implant recipients for meningitis and 
pneumococcal disease; update on the effect of pneumococcal conjugate 
vaccine on disease; update on the Institute of Medicine Immunization 
Safety Review Committee meetings; and Glaxo SmithKline's combination 
DTaP-HepB-IPV vaccine. Agenda items are subject to change as 
priorities dictate.

    For More Information Contact: Gloria A. Kovach, Program Analyst, 
Epidemiology and Surveillance Division, National Immunization Program, 
CDC, 1600 Clifton Road, NE., m/s E61, Atlanta, Georgia 30333. Telephone 
404/639-8096.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

    Dated: September 11, 2002.
John Burckhardt,
Acting Director, Management Analysis and Services Office, , Centers for 
Disease Control and Prevention.
[FR Doc. 02-23556 Filed 9-16-02; 8:45 am]
BILLING CODE 4163-18-P